Sort by
Hemocompatibility of Membrane Lung Components from Extracorporeal Membrane Oxygenation with Different Antithrombogenic Coatings
Christopher Thaus,
Elena Hofrichter,
Matthias Lubnow,
Lars Krenkel,
Karla Lehle
Posted: 06 December 2024
Single-Cell RNA Sequencing Reveals LEF1-Driven Wnt Pathway Activation as a Shared Oncogenic Program in Hepatoblastoma and Medulloblastoma
Christophe Desterke,
Yuanji Fu,
Jenny Bonifacio-Mundaca,
Claudia Monge,
Pascal Pineau,
Jorge Mata-Garrido,
Raquel Francés
(1) Background: Hepatoblastoma and medulloblastoma are two types of pediatric tumors with embryonic origins. Both tumor types can exhibit genetic alterations that affect beta-catenin and Wnt pathway; (2) Materials and Methods: This study used bioinformatics and integrative analysis of multi-omics data at both the tumor and single-cell levels to investigate these two distinct pediatric tumors: medulloblastoma and hepatoblastoma; (3) Results: Cross-transcriptome analysis revealed a commonly regulated expression signature between hepatoblastoma and medulloblastoma tumors. Among the commonly upregulated genes, the transcription factor LEF1 was significantly expressed in both tumor types. In medulloblastoma, LEF1 upregulation is associated with the WNT-subtype. Analysis of LEF1 genome binding occupancy in H1 embryonic stem cells identified 141 LEF1 proximal targets activated in WNT-medulloblastoma, 13 of which are involved in Wnt pathway regulation: RNF43, LEF1, NKD1, AXIN2, DKK4, DKK1, LGR6, FGFR2, NXN, TCF7L1, STK3, YAP1, and NFATC4. An expression score based on these 13 WNT-LEF1 targets accurately predicted the WNT-subtype in two independent medulloblastoma transcriptome cohorts. At the single-cell level, the WNT-LEF1 expression score was exclusively positive in WNT-medulloblastoma tumor cells. This WNT-LEF1-dependent signature was also confirmed as activated in the hepatoblastoma tumor transcriptome. At the single-cell level, the WNT-LEF1 expression score was higher in tumor cells from both human hepatoblastoma samples and a hepatoblastoma patient-derived xenotransplant model; (4) Discussion: This study uncovered a shared transcriptional activation of a LEF1-dependent embryonic program, which orchestrates the regulation of the Wnt signaling pathway in tumor cells from both hepatoblastoma and medulloblastoma.
(1) Background: Hepatoblastoma and medulloblastoma are two types of pediatric tumors with embryonic origins. Both tumor types can exhibit genetic alterations that affect beta-catenin and Wnt pathway; (2) Materials and Methods: This study used bioinformatics and integrative analysis of multi-omics data at both the tumor and single-cell levels to investigate these two distinct pediatric tumors: medulloblastoma and hepatoblastoma; (3) Results: Cross-transcriptome analysis revealed a commonly regulated expression signature between hepatoblastoma and medulloblastoma tumors. Among the commonly upregulated genes, the transcription factor LEF1 was significantly expressed in both tumor types. In medulloblastoma, LEF1 upregulation is associated with the WNT-subtype. Analysis of LEF1 genome binding occupancy in H1 embryonic stem cells identified 141 LEF1 proximal targets activated in WNT-medulloblastoma, 13 of which are involved in Wnt pathway regulation: RNF43, LEF1, NKD1, AXIN2, DKK4, DKK1, LGR6, FGFR2, NXN, TCF7L1, STK3, YAP1, and NFATC4. An expression score based on these 13 WNT-LEF1 targets accurately predicted the WNT-subtype in two independent medulloblastoma transcriptome cohorts. At the single-cell level, the WNT-LEF1 expression score was exclusively positive in WNT-medulloblastoma tumor cells. This WNT-LEF1-dependent signature was also confirmed as activated in the hepatoblastoma tumor transcriptome. At the single-cell level, the WNT-LEF1 expression score was higher in tumor cells from both human hepatoblastoma samples and a hepatoblastoma patient-derived xenotransplant model; (4) Discussion: This study uncovered a shared transcriptional activation of a LEF1-dependent embryonic program, which orchestrates the regulation of the Wnt signaling pathway in tumor cells from both hepatoblastoma and medulloblastoma.
Posted: 06 December 2024
Comparative Transcriptional Analysis of Long Noncoding RNAs in Oxidative Stress and toxicology Induced by Potassium Permanganate and Lipopolysaccharide in Rat Uterine Tissues
Talha Umar,
Huili Feng,
Wen Feng,
Han Zhou,
Nuoer Chen,
Jinxin Zhang,
Wenjing Liu,
Xiao Wang,
Saqib Umer,
Zaima Umar
Posted: 06 December 2024
Study a Collection of Watermelons for a Mutation Affecting Male Sterility
Nikolay Velkov Velkov
Posted: 06 December 2024
The First Report on the Artificial Cultivation Techniques of Buchwaldoboletus xylophilus (Boletales, Boletaceae, Buchwaldoboletus) in Southwest China
Tianwei Yang,
Hongjun Mu,
Liming Dai,
Jing Liu,
Xinjing Xu,
Feng Gao,
Yiwei Fang,
Sipeng Jian,
Mingxia He,
Chunxia Zhang
Posted: 06 December 2024
Calibrating Human Immunity in the Context of Advanced Microbial Evolution and Self-Camouflaging
Theodor-Nicolae Carp
The concept of microbial evolution has become progressively intriguing for the immunological side of scientific research, as the ongoing evolutionary battle between microbial agents and animal immunity, which comprises a set of single-nucleotide polymorphisms (SNPs) for both the microbes and the host organisms by means of adaptation to environmental changes, has started including weak points within the innate host immunity as well. Namely, it was discovered only later in the contemporary era that microbial agents tend to use a method of silencing first and second immune lines as an escaping route toward an abundant distribution of the microbial load without a significant restriction from the host organism at the time. Furthermore, it was discovered that the innate immune system displays visible traits of specificity and memory, and also that the adaptive immune system does contain areas of non-specificity as well, which makes it possible for vaccine-based research efforts to bring a wider inclusion of innate, first-line and second-line immune elements into the overall equation of development and possibly rollout as well, perhaps by using such elements as potential immunising agents as well. Additionally, it is possible for central elements of the adaptive immune system to be treated with major elements of the innate immune system by means of improving their overall function and long-term efficacy against pathogenic agents of potential health concern. Such a context may also be adapted for a potential delay in the onset of specific proteinopathies, such as Alzheimer’s Disease and possibly Retinitis Pigmentosa as well. An overall approach as such may help the research area of vaccine development undergo potential updates that will potentially help save even more lives worldwide, through the development and application of a scientific concept known as “United Immune System”, as it may be important to transform the smaller and less direct “road” between natural and adaptive immunity into a broader and more direct “highway” between the two immune departments. Such a clinical application may be combined with potential fresh updates into pathogen-derived vaccine development, by using inactivated or completely lysed microbial genomes either lacking the genes encoding microbial proteins with suppressive effects against the host innate immune system, or containing such genes as the only activated microbial genes, to stimulate the host immune system to build novel evolutionary pathways and particularly adapt to changes in the microbial genome that affect the innate immune system, such as the expression of Type I and Type III Interferons.
The concept of microbial evolution has become progressively intriguing for the immunological side of scientific research, as the ongoing evolutionary battle between microbial agents and animal immunity, which comprises a set of single-nucleotide polymorphisms (SNPs) for both the microbes and the host organisms by means of adaptation to environmental changes, has started including weak points within the innate host immunity as well. Namely, it was discovered only later in the contemporary era that microbial agents tend to use a method of silencing first and second immune lines as an escaping route toward an abundant distribution of the microbial load without a significant restriction from the host organism at the time. Furthermore, it was discovered that the innate immune system displays visible traits of specificity and memory, and also that the adaptive immune system does contain areas of non-specificity as well, which makes it possible for vaccine-based research efforts to bring a wider inclusion of innate, first-line and second-line immune elements into the overall equation of development and possibly rollout as well, perhaps by using such elements as potential immunising agents as well. Additionally, it is possible for central elements of the adaptive immune system to be treated with major elements of the innate immune system by means of improving their overall function and long-term efficacy against pathogenic agents of potential health concern. Such a context may also be adapted for a potential delay in the onset of specific proteinopathies, such as Alzheimer’s Disease and possibly Retinitis Pigmentosa as well. An overall approach as such may help the research area of vaccine development undergo potential updates that will potentially help save even more lives worldwide, through the development and application of a scientific concept known as “United Immune System”, as it may be important to transform the smaller and less direct “road” between natural and adaptive immunity into a broader and more direct “highway” between the two immune departments. Such a clinical application may be combined with potential fresh updates into pathogen-derived vaccine development, by using inactivated or completely lysed microbial genomes either lacking the genes encoding microbial proteins with suppressive effects against the host innate immune system, or containing such genes as the only activated microbial genes, to stimulate the host immune system to build novel evolutionary pathways and particularly adapt to changes in the microbial genome that affect the innate immune system, such as the expression of Type I and Type III Interferons.
Posted: 06 December 2024
May a Clinical Implementation of the United Immune System Concept Help Delay the Onset of Degenerative Proteinopathies?
Theodor-Nicolae Carp
Posted: 06 December 2024
Evaluation of a Serological Assay Based on Immunodominant Bi-Specific Peptides for Diagnosing Lyme Disease
Mônica E.T.A Chino,
Virgínia L.N. Bonoldi,
Rosa M. Pereira,
Gilberto S. Gazeta,
Paloma Napoleão-Pêgo,
João P.R.S. Carvalho,
Andressa M. Durans,
André L.A. Souza,
Carlos M. Morel,
David W. Provance-Jr
Posted: 06 December 2024
Variation in cone and seed productions of Cedrus libani A. Rich. populations
Nebi Bilir,
Arthur I. Novikov,
Tatyana P. Novikova
Posted: 06 December 2024
Microbial Ecology: Understanding the Dynamics of Microbial Communities and Their Impact on Ecosystems
Emmanuel Idowu
Posted: 06 December 2024
of 1,641